A vacation bench of justices Gautam Ankhad and Sandesh D Patil observed that denying the crypto platform access to banking facilities severely affects its functioning ...

The Bombay High Court has directed Yes Bank to restore API and banking services to crypto exchange platform WazirX, observing ...

Dr. Reddy’s launches Obeda, an affordable oral semaglutide biosimilar for type 2 diabetes, enhancing treatment options in ...

Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three tablet strengths for daily use. This launch expands access to ...

The once-daily prescription tablet for type 2 diabetes received CDSCO approval after a Phase III trial showed comparable ...

What exactly was SAP up to with their SAP API policy changes - and updates? No one better to ask than Dr. Philipp Herzig, CTO ...

Here's how you can put Anthropic's claims to the test.

Hyderabad pharma giant Dr. Reddy’s Laboratories on Wednesday announced the launch of its oral semaglutide biosimilar, marketed under the brand name ‘Obeda®’, for the treatment of Type 2 diabetes ...

Dr Reddy’s Labs launches oral semaglutide biosimilar ‘Obeda’ tablets in India: Our Bureau, Bengaluru Wednesday, May 20, 2026, 17:25 Hrs [IST] Dr Reddy’s Laboratories has l ...

Explore the latest AI updates including Google Gemini 3.5 Pro X-High, Anthropic Claude Lab features, and Xiaomi MiMO 2.5 pricing cuts.

The Infinite Loop by Nebius reports on the rise of AI-enabled vibe coding, exemplified by Base44, which allows users to ...

Leslee Johnson, the founding editor of The Intersection, a bimonthly newspaper, shines light on the challenges of an ...